These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; DueƱas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326 [TBL] [Abstract][Full Text] [Related]
5. 'Rescue' therapies for the management of Helicobacter pylori infection. Di Mario F; Cavallaro LG; Scarpignato C Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270 [TBL] [Abstract][Full Text] [Related]
15. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Gisbert JP; Calvet X Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241 [TBL] [Abstract][Full Text] [Related]
16. Practical treatment of Helicobacter pylori: a balanced view in changing times. Smith SM; Haider RB; O'Connor H; McNamara D; O'Morain C Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):819-25. PubMed ID: 24892516 [TBL] [Abstract][Full Text] [Related]
17. Toward population specific and personalized treatment of Helicobacter pylori infection. Liou JM; Chen PY; Kuo YT; Wu MS; J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083 [TBL] [Abstract][Full Text] [Related]
19. Current options for the treatment of Helicobacter pylori. Georgopoulos SD; Papastergiou V; Karatapanis S Expert Opin Pharmacother; 2013 Feb; 14(2):211-23. PubMed ID: 23331077 [TBL] [Abstract][Full Text] [Related]
20. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients. Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]